Esperion Therapeutics Inc (ESPR) reports a 144% revenue surge in Q4 2025, driven by strategic partnerships and successful commercial execution.

Hunter Greene will miss up to four months due to a scope surgery to address bone spurs and "loose bodies" in his right elbow, per the Cincinnati Reds.

Brazilian drugmaker EMS is open to fresh acquisitions to expand internationally after inking a major deal ‌to buy Sanofi's Brazil-based generic drugmaker Medley, and is gearing up to launch ‌its own ...